Jarett represents institutional investors, hedge funds and other investors in connection with business valuation matters, fiduciary duty claims, shareholder rights, securities claims, and other complex commercial disputes.  Jarett has extensive experience litigating all aspects of a business valuation dispute in Delaware Chancery and other courts around the country -- from inception to trial and on appeal. As a go-to member of the RKS trial team, he focuses on using the legal process to create value for shareholders. 

As a frequent contributor of RKS’ Valuation and Shareholder Rights Blog, an online forum providing extensive coverage of issues of shareholder and investor rights,  Jarett is appreciated for his insights on value-enhancing tools available to investors.

Jarett is also committed to pro bono service, including obtaining asylum for children.  Prior to joining the firm, Jarett served as a judicial clerk to the Hon. Allison E. Accurso of the Superior Court of New Jersey, Appellate Division.

Representative Matters:

  • Litigated numerous business valuation disputes on behalf of institutional investors in Delaware Chancery Court that have resulted in confidential settlements at various stages of the litigation, including early on in discovery and at the eve of trial.  Matters include actions against a major healthcare company, a medical transport company, a telecommunications company, a leading distributor of refrigerated foods, as well as others.
  • Litigated numerous valuation disputes to trial, including discounted cash flow inputs, adjustments to projections, perpetuity growth rate assumptions, and control premiums.
  • Representing multiple investors including Janus Capital Group, SunAmerica Asset Management, Brahman Capital, MSD Partners, Grantham, Mayo, Van Otterloo & Co., Discovery Capital Management, and Incline Global Management against Valeant Pharmaceuticals International, Inc. and certain of its executives in a case dubbed the “pharmaceutical Enron.”
  • Successfully defended the rights of shareholders of HRG Group Inc. to be fairly and adequately represented in a recent proposed securities class action settlement.
  • Representing a long-time client Special Situations Funds as co-lead counsel for a class of public investors in the securities of Chembio Diagnostics for misstatements made about its COVID-19 antibody test.


Jarett is a contributor to the RKS Valuation Litigation and Shareholder Rights (VLSR) blog, a clearinghouse for news and analysis involving global issues of shareholder and investor rights, including investor’s ability to use appraisal litigation to preserve value in mergers and other corporate events.


Numerous media organizations have covered the formation of Rolnick Kramer Sadighi LLP, a “premier securities litigation boutique dedicated to serving the investment management industry, including hedge funds, mutual funds, private equity, credit, real estate and structured finance firms.” Other outlets covering the formation include:; NJBiz;; and